Medication reduces risk of heart irregularities after cardiac surgeryDecember 29, 2005Use of the medication amiodarone is associated with one-half the incidence of atrial tachyarrhythmias (rapid, abnormal heart beat) following cardiac surgery, according to a study in the December 28 issue of JAMA. Atrial tachyarrhythmias, usually atrial fibrillation or atrial flutter, often occur immediately after cardiac surgery and are the most common postoperative complication, according to background information in the article. The incidence of sustained atrial tachyarrhythmias after coronary artery bypass graft (CABG) surgery is approximately 30 percent; after valve surgery, approximately 40 percent; and after combined CABG and valve replacement/repair surgery, approximately 50 percent. The consequences of these atrial tachyarrhythmias include discomfort or anxiety, stroke, exposure to the risks of tachyarrhythmia treatments, prolongation of hospital stay, and increased health care costs. Atrial tachyarrhythmias have recently been reported to increase hospital stay after cardiac surgery by an average of 1.4 days at an additional cost of $6,356 per patient. Substantial effort has been invested in finding an effective, safe, and widely applicable preventive treatment for atrial tachyarrhythmia occurring after cardiac surgery. Previous trials of amiodarone were relatively small and yielded conflicting results. L. Brent Mitchell, M.D., and colleagues from the University of Calgary, Canada, conducted the Prophylactic Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair (PAPABEAR) trial to test the hypothesis that amiodarone is an effective, well-tolerated, and safe therapy for prevention of atrial tachyarrhythmias after cardiac surgery. The placebo-controlled, randomized trial compared younger patients (less than 65 years) with older patients (65 years or older), patients undergoing CABG surgery compared with patients undergoing cardiac valve surgery or combined CABG and valve replacement/repair surgery, and patients who received preoperative beta-blocker therapy with those who did not. The study included 601 patients who had CABG surgery and/or valve replacement/repair surgery between February 1, 1999, and September 26, 2003. The patients were followed up for 1 year. Patients received oral amiodarone or placebo, administered 6 days prior to surgery through 6 days after surgery (total of 13 days). Amiodarone was associated with a halving of the overall incidence of atrial tachyarrhythmias lasting 5 minutes or longer. Postoperative sustained ventricular tachyarrhythmias occurred less frequently in amiodarone patients (1/299; 0.3 percent) than in placebo patients (8/302; 2.6 percent). There were no differences in serious postoperative complications, in-hospital mortality, or readmission to the hospital within 6 months of discharge or in 1-year mortality. "The number needed to treat [with amiodarone] to prevent 1 patient from developing postoperative atrial tachyarrhythmia was only 7.5 overall and was even lower in older patients, in patients having valve surgery, and in patients not receiving concomitant beta-blocker therapy," the authors write. "The PAPABEAR trial demonstrates that a 13-day perioperative course of oral amiodarone is an effective, possibly safe, well-tolerated, and widely applicable therapy for the prevention of postoperative atrial tachyarrhythmia after cardiac surgery. This benefit was associated with a reduction in the probability of perioperative sustained ventricular tachyarrhythmia and a trend toward a reduction in postoperative hospital stay," the researchers conclude. JAMA and Archives Journals |
|||||||||||||||||||||
| Related Cardiac Surgery Current Events and Cardiac Surgery News Articles Surgery not linked to memory problems in older patients For years, it has been widely assumed that older adults may experience memory loss and other cognitive problems following surgery. But a new study from researchers at Washington University School of Medicine in St. Louis questions those assumptions. Experts unveil new CVD guidelines and position papers Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week. MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition MedImmune announced today it will present four abstracts at the American Academy of Pediatrics (AAP) 2009 National Conference & Exhibition that add to the company's growing body of research on the burden of respiratory syncytial virus (RSV) on children, as well as pediatric infectious disease prevention. Study details safe, effective, minimally invasive mitral valve repair Surgical treatment for mitral valve disease includes either repairing the patient's diseased valve or replacing it with a metal, mechanical valve or an animal tissue valve. Is there long-term brain damage after bypass surgery? More evidence puts the blame on heart disease Brain scientists and cardiac surgeons at Johns Hopkins have evidence from 227 heart bypass surgery patients that long-term memory losses and cognitive problems they experience are due to the underlying coronary artery disease itself and not ill after-effects from having used a heart-lung machine. Is RTA a new potential option for the treatment of hydatid cysts? Current treatment of cystic echinococcosis is surgery or percutaneous aspiration, injection and reaspiration (PAIR) using hypertonic saline or ethanol. Mayo Study Finds That Team Preop Briefing Improves Communication, Reduces Errors A short, preoperative team briefing prior to cardiac surgery - where each person on the team speaks - improves communication and reduces errors and costs, according to a pilot study conducted at Mayo Clinic. Different treatment options in chronic coronary artery disease Sometimes cardiologists and cardiac surgeons can agree! There is often disagreement between the professions of cardiology and cardiac surgery about the proper therapy for coronary artery disease (CAD)-and this can harm the patient. Omega-3 Fatty Acids May Benefit Cancer Patients Undergoing Major Operations New research from Trinity College Dublin published in this month's Annals of Surgery points to a potentially significant advance in the treatment of patients undergoing major cancer surgery. Study reveals worrying survival gap between rich and poor after heart surgery People from the most deprived areas of England have a far higher risk of death after cardiac surgery than people from the least deprived areas, finds a large study published on bmj.com today. More Cardiac Surgery Current Events and Cardiac Surgery News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||